secwatch.observer — SEC 8-K summary
======================================

Issuer:     BridgeBio Pharma, Inc. (BBIO)
CIK:        0001743881
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001140361-24-001358
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BridgeBio Pharma presents business update at 42nd Annual J.P. Morgan Healthcare Conference
--------------------------------------------------------------------------------

- BridgeBio Pharma presented a business update at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
- The presentation slides were filed as Exhibit 99.1 to the Form 8-K and published on the company's website.
- The update was signed by CFO Brian C. Stephenson.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1743881/000114036124001358/0001140361-24-001358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1743881/000114036124001358/ef20018306_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-001358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer